21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Method for producing probiotically derived compounds
#24902Methods for minimizing spasticity in blood vessel grafts
#24903Method for configuring air-core photonic-bandgap fibers free of surface modes
#24904Physiologically synergistic mixtures of fruit components, methods of preparation thereof and methods of use thereof
#24905Composition for weight reduction comprising water-soluble low-molecular weight chitosan and Hibiscus extract
#24906Dioscorea extracts
#24907Formulations and methods for treating breast cancer with Morinda citrifolia and methylsulfonymethane
#24908Process for producing fat composition containing hydrophobic components of glycyrrhiza
#24909Compositions and methods for treatment of nervous system disorders
#24910Compositions and methods for inhibiting 5-alpha reductase
#24911Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same
#24912Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects
#24913Composition
#24914Extended release alpha-2 agonist pharmaceutical dosage forms
#24915Systemic delivery of serum stable plasmid lipid particles for cancer therapy
#24916Androgen pharmaceutical composition and method for treating depression
#24917Methods and compositions for regenerating connective tissue
#24918Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
#24919Inhibition of using botanical extracts
#24920Solid compositions containing compounds unstable to oxygen and method for stabilization thereof
#24921Oral vaccine, method for its preparation and use thereof
#24922Combinations and methods for treating neoplasms
#24923Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
#24924Compositions and methods to accelerate hematologic recovery
#24925Treatment of micro-organism infection
#24926Pharmacological vitreolysis
#24927Storage-stable fibrin sealant
#24928Antioxidant combination composition and use thereof
#24929Lipid A-type compound and composition containing it
#24930Methods and compositions comprising diamines as new anti-tubercular therapeutics
#24931Composition and dosage form for sustained effect of levodopa
#24932Composition that comprises ozonised oils and/or other natural and/or synthetic ozonised products, and use thereof in pharmaceutical, cosmetic, dietary or food supplement products, in the human and veterinary fields
#24933Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system
#24934Use of peroxynirite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence
#24935Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disorders
#24936Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith
#24937Combinations of (a) an atp-competitive inhibitor of c-acl kinase activity with (b) two or more other antineoplastic agents
#24938Pyridazinone aldose reductase inhibitors
#24939Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury
#24940Antifungal agent for topical use
#24941Pharmaceutical composition
#24942Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome
#24943Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR)
#24944Bioavailable prodrugs of androgenic steroids and related method
#24945Pharmaceutical composition and method for treating hypogonadism
#24946Composition and method
#24947Compositions for ameliorating fecal properties
#24948Compositions and methods for treating an arthritic condition
#24949Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors
#24950DAPD combination therapy with inosine monophosphate dehydrogenase inhibitor
#24951Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
#24952Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
#24953Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases
#24954Methods of treating cancer and the pain associated therewith using endothelin antagonists
#24955Methods of treating cancer and the pain associated therewith using endothelin antagonists
#24956Compounds and methods for modulating cell-adhesion mediated drug resistance
#24957Treatment of subnormal bone mineral density
#24958Use of SARP-1 for the treatment and/or prevention of scleroderma
#24959Composition to enhance joint function and repair
#24960Vapor fraction from seeds of (L.) Merr. and composition thereof
#24961Saccharide compositions and method of use
#24962Herbal formulation
#24963Eye nutritional supplement
#24964Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
#24965EDTA containing compositions and uses thereof
#24966Therapeutic regimens for administering drug combinations
#24967Drug coating providing high drug loading
#24968Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal
#24969Pharmaceutical composition and method for treating hypogonadism
#24970Nutritional dietary kit for use in preparing an individual for gastrointestinal procedure
#24971Nutritional supplement composition and method
#24972Dermatological composition
#24973Polypeptide expressed in the horny layer of the epidermis and its use
#24974Enhanced B cell cytotoxicity of CDIM binding antibody
#24975Inhibition of protein kinase c-mu (PKD) as a treatment for cardiac hypertrophy and heart failure
#24976Methods of treating proteinuria
#24977Generation of hematopoietic chimerism and induction of central tolerance
#24978Presbyopia treatment by lens alteration
#24979Microorganism for treatment or prevention of corpulence and diabetes mellitus, and pharmaceutical composition containing the same
#24980Stabilized dihydrolipoic acid and method of producing same
#24981Compositions and treatments for myelosuppression by ex vivo activated immune cells
#24982Method for the treatment of cancer
#24983Combination therapy for HCV infection
#24984Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
#24985Death domain containing receptor 4 antibodies and methods
#24986Plant-derived protein extract compositions and methods
#24987Hypoestoxides, derivatives, agonists and crude extracts thereof for use in cosmetic compositions
#24988Pharmaceutical composition of a pde4 or pde 3/4 inhibitor and histamine receptor antagonist
#24989Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity
#24990Use of a VEGF antagonist in combination with radiation therapy
#24991Enhancement of radiotherapy by an exogenous cardiac glycoside
#24992Reduction of Contaminants In Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light
#24993Decontamination formulations for disinfection and sterilization
#24994Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents
#24995Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia
#24996Composition for treating inflammatory bowel disease
#24997Prostamides for the treatment of glaucoma and related diseases
#24998Drug combination therapy
#24999Black soybean polysaccharides
#25000Dosing regimen for ppar-gamma activators
#25001Pharmaceutical compositions of amlodipine and atorvastatin
#25002Composition and method for treating emesis
#25003Treatment of attention defecit hyperactivity disorder
#25004Imidazonaphthyridines
#25005Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
#25006Medicaments for inhalation comprising a novel anticholinergic and a betamimetic
#2500717-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
#25008Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders
#25009Brain, spinal and nerve injury treatment
#25010Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease
#25011Agents for the prevention or treatment of renal diseases
#25012Methods of treating lower urinary tract disorders using losigamone
#25013Graduated estrogen contraceptive
#25014Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
#25015N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity
#25016Nutritional supplement enhancing mitochondrial function
#25017Pharmaceutical composition for the treatment of rhinitis
#25018Cardiac arrhythmia treatment methods
#25019Methods and compositions for use in interventional pharmacogenomics
#25020Treatment of respiratory disease associated with matrix metalloproteases by inhalation of synthetic matrix metalloprotease inhibitors
#25021Wound healing composition and method for use thereof
#25022Treatment of cancers by inhalation of stable platinum-containing formulations
#25023Storage of materials
#25024Pharmaceutical composition made from Chinese traditional medecine and method of producing thereof
#25025Appetite suppressant
#25026Co-beadlet of dha and rosemary and methods of use
#25027Eye drops
#25028Increasing cerebral bioavailability of drugs
#25029Green tea, multivitamin, mineral and herb based hair and male facial skin formulas
#25030Pharmaceutical composition comprising arsenite for the treatment of malignancy
#25031Method for the accelerated in vivo removal of ethanol
#25032Pharmacology and manufacturing method of Bombyx moriL related bioproduct
#25033Once-a-day, oral, controlled-release, oxycodone dosage forms
#25034Controlled release arginine α-ketoglutarate
#25035Ibuprofen and narcotic analgesic compositions
#25036Calcium formate for use as a dietary supplement
#25037Compositions and methods for treatment of body weight conditions
#25038Food or pet food composition containing plant extract for bone health
#25039Endoparasiticidal gel composition
#25040Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
#25041Method of treating pain
#25042Additive for livestock feed
#25043Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
#25044Method of treating anemia by administering IL-1ra
#25045Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues
#25046Growth promoting prebiotic for lactobacillus dietary supplements
#25047Photoprotective orally administrable composition for skin
#25048Novel methods of treatment and deliver modes
#25049Antimicrobial composites, films, labelstocks, and labels
#25050Composition for the treatment of dental and periodontal diseases
#25051Anti-microbial tool grip
#25052PPMP as a ceramide catabolism inhibitor for cancer treatment
#25053Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
#25054Androgen receptor antagonists
#25055Migraine treatments including isovaleramide compounds and serotonin agonists
#25056Combination therapy for the treatment of migraine
#25057Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist
#25058Lisinopril/lercanidipine combination therapy
#25059Combination of organic compounds
#25060Method for the treatment of inflammation
#25061Compositions of a chromene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system
#25062Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer
#25063Pharmaceutical composition containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha reductase inhibitor
#25064Oral liquid formulations of methotrexate
#25065Compositions of a cyclooxygenase-2 selective inhibitior and a non-NMDA glutamate modulator for the treatment of central nervous system damage
#25066Compositions useful as inhibitors of protein kinases
#25067Topical skin care composition
#25068Endometriosis treatment protocol
#25069Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
#25070Methods of treating cancer using a combination of drugs
#25071Pharmaceutical compositions and methods for treating, preventing, and managing cholesterol, dyslipidemia, and related disorders
#25072Method and compositions for the treatment and prevention of pain and inflammation
#25073HDL-boosting combination therapy complexes
#25074Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
#25075Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
#25076Combination therapy for controlling appetites
#25077Use of exendins and agonists thereof for lowering plasma lipid
#25078Use of a synthetic alpha-melanocyte stimulating hormone agonist to decrease steroid induced weight gain
#25079Preparation for the prophylaxis of restenosis
#25080Gene expression profile for KSHV infection and methods for treating same
#25081Microbiological control in poultry processing
#25082Carbohydrate and electrolyte replacement composition
#25083Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
#25084Dermatological compositions
#25085Compositions of oak bark extract, related synthetic compositions, and method of using same
#25086Cholesterol lowering supplement
#25087Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of Icariin, a herbal product produced from the Epimedium genus of the Berberidaceal family of plants, for the treatment of sexual dysfunction
#25088Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
#25089Process for controlling water and electrolyte balance and acid-base equilibrium in human body
#25090Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
#25091Virucidal activities of cetylpyridinium chloride
#25092Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
#25093Use of bioactive fraction from cow urine distillate (‘’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
#25094Virucidal activities of cetylpyridinium chloride
#25095Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
#25096Methods for treatment of human skin damaged by laser treatment or chemical peelings and compositions useful in such methods
#25097Topical analgesic and methods of use
#25098Liquid concentrate for the preservation of cosmetic and pharmaceutical products
#25099Cytotoxicity mediation of cells evidencing surface expression of CD44
#25100Intradiscal injection of anti-oxidants
#25101Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals
#25102Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
#25103Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
#25104Antibiotic polymers
#25105Skin formulation
#25106Homeopathic method and system for treating nicotine addiction
#25107Compositions comprising fenofibrate and rosuvastatin
#25108Compositions comprising fenofibrate and pravastatin
#25109Iminothiazolidinones as inhibitors of HCV replication
#25110Tyrosine kinase inhibitors
#25111Morphogen-induced modulation of inflammatory response
#25112Treatment of cancers with methylol-containing compounds and at least one electrolyte
#25113Compositions and methods for treatment of nervous system disorders
#25114Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
#25115Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementation
#25116Method of treating cancer using dithiocarbamate derivatives
#25117Cardiovascular protection using anti-aldosteronic progestins
#25118Treatment of hypercholesterolemia or diabetes associated angiogenic defects
#25119Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
#25120Helicobacter pylori adhesion inhibitor
#25121Combination therapy for the treatment of ocular neovascular disorders
#25122Compositions for manipulating the lifespan and stress response of cells and organisms
#25123Method for production of oncolytic adenoviruses
#25124Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments
#25125Composition and method for smoke detoxification
#25126Stable beadlets of lipophilic nutrients
#25127Controlled release analgesic suspensions
#25128Decongestant and expectorant tablets
#25129Neuropathy cream
#25130Drug delivery to the inner ear and methods of using same
#25131Multivitamin syrup for children or young adults
#25132Therapeutical combination against cancer
#25133Fully human antibodies against human 4-1BB
#25134Combination therapy for B cell disorders
#25135Method of administering an antibody
#25136Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5
#25137Vaginal care composition
#25138Modified adenovirus containing a fiber replacement protein
#25139Compositions and method for treating hepatitis virus infection
#25140Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
#25141Method of stabilizing compound having quinone skeleton and stabilized composition
#25142Substituted bicylo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
#25143Compositions and method for treatment of chronic inflammatory diseases
#25144Therapeutic use of methionine for the treatment or prevention of mucositis
#25145Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
#25146Nitric oxide topical technology
#25147Method for the preparation of tetrahydrobenzothiepines
#25148Analgesic and anti-inflammatory compositions containing Cox-2-inhibitors
#25149Pharmaceutical composition based on a polymorphic form I of idazoxan
#25150Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
#25151Treatment of disease or injury of the nervous system with FTY720
#25152Method for treating parkinson's disease using apomorphine and apomorphine prodrugs
#25153Pharmaceutical combinations of cox-2 inhibitors and opiates
#25154Method of preventing infectious diseases
#25155Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
#25156Drug combination for the treatment of depression and related disorders comprising mirtazapine
#25157Potentiators of antibacterial activity
#25158Use of selected amino acid-zinc complexes as anti-malarials
#25159Extended triphasic contraceptive regimens
#25160Methods and compositions for enhancing and inhibiting fertilization
#25161Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
#25162Treatment of cancer with glutamine
#25163Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#25164Dalbavancin compositions for treatment of bacterial infections
#25165Use of melagatran for the manufacture of a medicament for the treatment of Type 1 diabetes mellitus
#25166Antibodies for inhibiting blood coagulation and methods of use thereof
#25167Nut skin products
#25168Dietary supplements containing natural ingredients
#25169Procedure for the preparation of microbiological associations intended to strengthen the medicinal herb's therapeutic qualities
#25170Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof
#25171Methods and compositions for oral delivery of Areca and mate' or theobromine
#25172Herbal composition for the treatment of gastric ulcer
#25173Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
#25174Oros push-stick for controlled delivery of active agents
#25175Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
#25176Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
#25177Medicinal targeted local lipolysis
#25178Compositions and methods comprising complex carbohydrate and alpha-lactalbumin
#25179Antimicrobial compositions and methods
#25180Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids
#25181Treatment of Francisella infection with an IFN-gamma inducer and a chemotherapeutic agent
#25182Composition based on natural substances useful in the maintenance of the correct hydration of the skin
#25183Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
#25184Sulfacetamide formulations for treatment of rosacea
#25185Medicaments
#25186Potassium channel mediated delivery of agents through the blood-brain barrier
#25187Antioxidant sensor, methods and compositions
#25188Preparation and purification of synthetic capsaicin
#25189Bupropion to treat viral diseases
#25190Method and formulation for treating vascular disease
#25191Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
#25192Parmaceutical
#25193Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
#25194Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
#25195Mediated central nervous system compositions of a cyclooxygenase-2 selective inhibitor and a corticotropin releasing factor antagonist for the treatment of ischemic disorders or injury
#25196Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage
#25197Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of neoplasia
#25198Oral antidepressant formulation
#25199Production of pure stereoisomers of tricyclo[5.2.1.0]-dec-9-yl-xanthogenate and medicaments therefrom
#25200Fluoroquinolone formulations and methods of making and using the same